Earnscleugh Castle, a historic property in Central Otago, New Zealand, will reopen in September 2026 as a luxury bed and breakfast, Travel Weekly Australia reported. That reopening follows a NZ$11 million restoration carried out over five years by the owners Ryan Sanders and Marco Creemers. From November 2026 the castle will also serve as the exclusive base for Sanctum 7, a premium seven-day wellness retreat.
Earnscleugh Castle restoration
Earnscleugh Castle was built in the 1920s in the Jacobethan style, Travel Weekly Australia reported. The restored property now holds nine guest suites and rooms across its main structure and the renovated Coach House. Sanders and Creemers ran the five-year project, and the restoration featured on Grand Designs New Zealand Season 10. Earnscleugh Castle is now a small, high-value bed and breakfast rather than a large resort, and that scale sets the frame for everything the Sanctum 7 wellness retreat is built to do.
Sanctum 7 wellness retreat programme
Sanctum 7 will run as a premium seven-day wellness retreat from November 2026, Travel Weekly Australia reported. Each retreat caps guest numbers at 12, and the programme is built around a set of personalised wellness protocols. Those protocols include pre-retreat functional testing, tailored nutrition programmes, IV drips, breathwork, ice baths, yoga, sound healing, and daily nature immersion within the estate’s private grounds.
Ryan Sanders, the founder of Sanctum 7, said the castle offers an ideal setting for wellness and restoration, Travel Weekly Australia reported. He described the retreat as the culmination of practices that help restore balance and recentre people who spend their time attending to others. The programme, on his account, targets busy professionals and devoted parents rather than a general holiday market. Sanctum 7 is therefore a low-volume, high-touch product from the outset, a design choice that the twelve-guest cap makes explicit.
Where Sanctum 7 sits on the health tourism spectrum
Health tourism runs along a spectrum rather than a line, and Sanctum 7 sits toward the wellness end of it. The guests it names are not travelling to remedy a diagnosed condition; they are travelling to improve an already-sound state through rest, nutrition and movement in a private setting. Clinical involvement is light, the setting is a restored castle rather than an accredited clinic, and the intent is lifestyle and restoration rather than treatment. Wellness tourism is a borrowed domain for a medical-travel desk, so the reading here is offered as observation rather than as clinical judgement.
New Zealand has built its tourism name on exclusive, nature-based experiences rather than high-volume medical travel, and a twelve-guest castle retreat fits that pattern far more than it fits a hospital corridor. A low-volume, high-touch programme leans on a small number of guests each paying a premium rate, so every booking carries weight and every stay has to deliver on the protocol it advertises.
The middle of the spectrum is where the interesting questions sit, and Sanctum 7 reaches into it. Pre-retreat functional testing and IV drips are not spa treatments; they are the medicalised end of wellness, the same hybrid territory that longevity and healthspan retreats now occupy. A yoga class and a sound-healing session carry no clinical risk. Functional testing that produces a result someone acts on, and an intravenous drip administered over a seven-day stay, are a different order of activity, and they change what a guest is entitled to ask about oversight.
The governance question
The account carries no detail on clinical governance, and that gap is worth naming. Travel Weekly Australia did not report who supervises the functional testing or administers the IV drips at Sanctum 7, nor whether any medical practitioner is attached to the retreat. The four standing risks of health travel apply unevenly across a programme like this. Yoga and breathwork sit outside them, but an intravenous drip carries a genuine clinical risk, and a guest recovering at a remote castle in Central Otago is a long way from a hospital if a reaction follows.
The specific move for the operator is disclosure. Sanctum 7 can settle most of the question by naming the clinician responsible for its functional testing and IV drips and the standard under which they work, and a retreat charging premium rates has every reason to publish that rather than leave it to inference. Pricing is the other omission. Travel Weekly Australia reported no rate for the seven-day retreat, and without it the market position of Sanctum 7 against other high-end wellness programmes cannot be read. On the restoration figure alone, NZ$11 million across nine rooms is roughly NZ$1.2 million per room, which places Earnscleugh Castle at the ultra-luxury end of New Zealand hospitality before a single retreat has run.
What to watch
Three things will show where Sanctum 7 lands. A published rate for the seven-day retreat will fix its position against established luxury wellness programmes in other high-value destinations. The disclosure, or absence, of named clinical oversight for the IV drips and functional testing will show how seriously the operator treats the medicalised half of its own protocols. Guest-origin data, once the retreat is running, will show whether Earnscleugh Castle draws an international wellness clientele or mainly high-net-worth visitors from New Zealand and Australia, and that answer will decide whether Sanctum 7 is a health tourism story or a domestic hospitality one.
